Introduction: Non-invasive assessment of fibrosis is increasingly utilized in clinical practice
to diagnose hepatic fibrosis. Non-invasive assessment of liver fibrosis relies on biologic …

Hepatic disease accounts for approximately 2 million deaths/year worldwide. Liver fibrosis,
as the last stage of numerous chronic liver diseases, is one of the most relevant prognostic …

Quantitative imaging biomarkers of liver disease measured by using MRI and US are
emerging as important clinical tools in the management of patients with chronic liver disease …

Objectives To investigate whether liver fibrosis can be staged by deep learning techniques
based on CT images. Methods This clinical retrospective study, approved by our institutional …

Elastography-based liver stiffness measurement (LSM) is a non-invasive tool for estimating
liver fibrosis but also provides an estimate for the severity of portal hypertension in patients …

Computed tomography (CT) is often chosen for the initial workup of focal and diffuse liver
disease because it is well tolerated, the images have few artifacts, and the entire abdomen …

Liver fibrosis is a reversible pathophysiological process correlated with intense repair and
cicatrization mechanisms, and its end-stage cirrhosis is responsible for high morbidity and …

Abstract Purpose The Liver Imaging Reporting and Data System (LI-RADS) was created to
standardize the diagnostic criteria for hepatocellular carcinoma (HCC) and has undergone …

Liver fibrosis (LF) is the wound healing response to chronic liver injury. LF is the endpoint of
chronic liver disease (CLD) regardless of etiology and the single most important determinant …

Background Extracellular volume (ECV) correlates with the degree of liver fibrosis. Purpose
To analyze the performance of liver MRI‐based ECV evaluations with different blood pool …